Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

New cytokine-targeted therapies show promise for treating alopecia areata.

Antigens from skin cells may cause hair loss in perinevoid alopecia.

Diphenylcyclopropenone is effective for treating alopecia areata but has a high relapse rate.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Triple horizontal scalp biopsies are 98% accurate in diagnosing hair loss, better than single biopsies.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Diuretics can cause serious side effects and should be used carefully.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Cilostazol may help hair grow and could be a new treatment for hair loss.

Panax ginseng might help with hair growth and has fewer side effects than synthetic treatments.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

The meeting highlighted major advances in skin research, including new findings on skin microbes, genetic links to skin diseases, and improved treatments for various conditions.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

A girl with symptoms like an autoimmune disorder actually had HIV and a fungal infection, which was hard to diagnose and treat, leading to her death.

Treatment with specific medications and supplements improved skin condition and hair regrowth in an Akita with sebaceous adenitis.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.